Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D and Cellular Senescence Pathways: Study Summary

Previous related pageVitamin D and Cellular Senescence Pathways: Full Evidence ReviewNext related pageVitamin D and Cellular Senescence Pathways: Full Evidence Review
Study at a glance

What question did the studies ask?

Researchers asked how vitamin D affects cells with features of senescence. Senescence is a state in which cells stop dividing for a long time but remain active. This review compares laboratory experiments and one small randomized human trial.

What did the researchers find?

Most laboratory studies used calcitriol, the active vitamin D hormone. Some experiments found changes in proteins involved in DNA repair. DNA is the material that carries genetic information. Others found lower release of selected inflammatory substances. Another improved a response to introduced DNA. These changes did not establish that the cells began dividing again or were removed. Other experiments found more senescence-associated features in injured human lung-cancer cells and kidney-cancer cells. Those models differ from healthy human tissue.

The human trial studied 88 older adults with low vitamin D levels. It compared two daily vitamin D3 doses, with or without N-acetylcysteine, for eight weeks. Higher-dose groups had lower selected blood-cell measurements than the lower dose alone. Some other measurements did not show a clear difference between groups. Blood inflammation measures did not show clear differences between groups. A staining result was not a direct count of senescent cells.

What does this mean?

Vitamin D can affect particular cell processes without establishing reversal of senescence. Laboratory hormone treatment, receptor deletion and oral vitamin D3 are different interventions. These studies did not establish that vitamin D clears senescent cells or slows ageing in people.

Read the full article below ↓

Vitamin D can affect particular processes in cells with senescence-associated features. Senescence involves cells stopping division for a long time while remaining active. DNA carries genetic information. Changes in its repair, inflammatory substances or cell measurements do not by themselves show that the cells were removed or began dividing again. For the detailed evidence, read Vitamin D and Cellular Senescence Pathways: Full Evidence Review.

What was studied?

The review compares laboratory experiments and a small randomized human trial. Different models used repeated cell growth, an activated cancer-related gene, exposure to radiation, chemical injury or malignant cells. These are different settings. Most cell experiments used calcitriol, the active vitamin D hormone. The human trial used oral vitamin D3. Vitamin D and Cellular Senescence introduces the wider cell biology.

What did the laboratory studies find?

Cells grown from human bone marrow grew more slowly with calcitriol and retained the ability to develop along several specialised routes. Some ageing-associated measurements changed, but the overall number of times the cells divided did not show a clear treatment difference. This did not establish an increase in how many times the cells could divide or a return to younger tissue function. The distinction from differentiation is explained in Vitamin D and Cell Differentiation. [1]

In fibroblasts, a type of connective-tissue cell, with an activated cancer-related gene, calcitriol restored selected DNA-repair proteins without preventing the senescent growth arrest. In skin fibroblasts already made senescent by irradiation, it lowered release of selected inflammatory substances. Lower secretion did not demonstrate cell removal or resumed division. [2] [3]

Other results pointed in a different direction. Calcitriol increased selected senescence-associated features in injured lung-cancer-derived cells and in a kidney-cancer cell model. Those findings cannot be transferred directly to healthy ageing tissues. Oxidative injury is one context discussed in Vitamin D and Oxidative Stress. [4] [5]

Another fibroblast study improved selected responses to introduced DNA. A separate lifespan result in that paper came from a different drug, not vitamin D. A skeletal study linked receptor signalling with cell-cycle regulation, but genetic deletion of a cell-cycle regulator was not vitamin D treatment or removal of senescent cells. [6] [7]

What did the human trial find?

Eighty-eight older adults with low vitamin D levels received 1,000 or 5,000 international units of vitamin D3 daily, with or without a separate substance called N-acetylcysteine, for eight weeks. Every group received vitamin D3; there was no placebo or N-acetylcysteine-only group. A correction confirms the higher dose was 5,000 units, not erroneous 50,000-unit table labels. These are research regimens, not personal dose recommendations. [8] [9]

The higher-dose groups had lower activity of selected genes and a lower staining measurement than the lower dose alone. The staining was green-pixel area, not a direct percentage of senescent cells. Other measurements did not show clear between-group differences, including activity of the gene called p21 and blood inflammation measures. The trial did not establish cell clearance or better resistance to infection or recovery from illness. [8]

How should the findings be interpreted?

Preventing senescence, reversing growth arrest, removing senescent cells and changing their secretions are separate claims. The experiments support changes in selected processes, with different responses across models. They do not establish that vitamin D reverses cell ageing or slows ageing in people. The broader tissue question belongs within Vitamin D and Age-Related Decline.

Scientific sources

[1] 1,25-dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity. Klotz B, Mentrup B, Regensburger M, Zeck S, Schneidereit J, Schupp N, Linden C, Merz C, Ebert R, Jakob F. PloS one. 2012;7(1):e29959. DOI 10.1371/journal.pone.0029959; PMID 22242193; PMCID PMC3252365.

[2] Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence. Graziano S, Johnston R, Deng O, Zhang J, Gonzalo S. Oncogene. 2016;35(41):5362-5376. DOI 10.1038/onc.2016.77; PMID 27041576; PMCID PMC5050051.

[3] Vitamin D3 inhibits p38 MAPK and senescence-associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing. Sayegh S, Fantecelle CH, Laphanuwat P, Subramanian P, Rustin MHA, Gomes DCO, Akbar AN, Chambers ES. Aging cell. 2024;23(4):e14093. DOI 10.1111/acel.14093; PMID 38287646; PMCID PMC11019144.

[4] Detrimental pro-senescence effects of vitamin D on lung fibrosis. Guijarro T, Magro-Lopez E, Manso J, Garcia-Martinez R, Fernandez-Aceñero MJ, Liste I, Zambrano A. Molecular medicine (Cambridge, Mass.). 2018;24(1):64. DOI 10.1186/s10020-018-0064-z; PMID 30567504; PMCID PMC6299997.

[5] Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation. Shen Y, Yu D, Qi P, Wang X, Guo X, Zhang A. Oncotarget. 2017;8(59):100187-100195. DOI 10.18632/oncotarget.22124; PMID 29245970; PMCID PMC5725012.

[6] A noncanonical cGAS-STING pathway drives cellular and organismal aging. Cancado de Faria R, Silva LND, Teodoro-Castro B, McCommis KS, Shashkova EV, Gonzalo S. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(28):e2424666122. DOI 10.1073/pnas.2424666122; PMID 40638086; PMCID PMC12280946.

[7] Active vitamin D protects against osteoporosis by promoting VDR-dependent CDK2 transcription and P27 degradation. Xu F, Liu Q, Huang M, Wang J, Goltzman D, Gu B, Miao D. European journal of endocrinology. 2026;195(2):329-344. DOI 10.1093/ejendo/lvag152; PMID 42592858.

[8] Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in immunology. 2025;16:1570441. DOI 10.3389/fimmu.2025.1570441; PMID 40421021; PMCID PMC12104082.

[9] Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in Immunology. 2025;16:1627178. DOI 10.3389/fimmu.2025.1627178; PMID 40510343.

Related reading

Physiology

Vitamin D and Cellular Senescence

Explains the relationship between vitamin D and cellular senescence, including gene regulation, mitochondrial function, oxidative stress, and inflammatory signalling, and how these processes relate to ageing cells.

Read more →

Original sources

Source

1,25-Dihydroxyvitamin D3 Treatment Delays Cellular Aging in Human Mesenchymal Stem Cells while Maintaining Their Multipotent Capacity

We wanted to know if 1,25D3 is able to modulate aging processes on a cellular level in human mesenchymal stem cells (hMSC).

Publication details

[1] 1,25-dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity. Klotz B, Mentrup B, Regensburger M, Zeck S, Schneidereit J, Schupp N, Linden C, Merz C, Ebert R, Jakob F. PloS one. 2012;7(1):e29959. DOI 10.1371/journal.pone.0029959; PMID 22242193; PMCID PMC3252365.

Read more →
Source

Vitamin D3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing

Vitamin D3 replacement in older insufficient adults significantly improves their antigen‐specific varicella zoster virus (VZV) cutaneous immunity.

Publication details

[3] Vitamin D3 inhibits p38 MAPK and senescence-associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing. Sayegh S, Fantecelle CH, Laphanuwat P, Subramanian P, Rustin MHA, Gomes DCO, Akbar AN, Chambers ES. Aging cell. 2024;23(4):e14093. DOI 10.1111/acel.14093; PMID 38287646; PMCID PMC11019144.

Read more →
Source

Detrimental pro-senescence effects of vitamin D on lung fibrosis

The multiple biological effects of vitamin D and its novel activities on inflammation and redox homeostasis have raised high expectations on its use as a therapeutic agent for multiple fibrogenic conditions.

Publication details

[4] Detrimental pro-senescence effects of vitamin D on lung fibrosis. Guijarro T, Magro-Lopez E, Manso J, Garcia-Martinez R, Fernandez-Aceñero MJ, Liste I, Zambrano A. Molecular medicine (Cambridge, Mass.). 2018;24(1):64. DOI 10.1186/s10020-018-0064-z; PMID 30567504; PMCID PMC6299997.

Read more →
Source

A noncanonical cGAS-STING pathway drives cellular and organismal aging.

[6] A noncanonical cGAS-STING pathway drives cellular and organismal aging.

Publication details

[6] A noncanonical cGAS-STING pathway drives cellular and organismal aging. Cancado de Faria R, Silva LND, Teodoro-Castro B, McCommis KS, Shashkova EV, Gonzalo S. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(28):e2424666122. DOI 10.1073/pnas.2424666122; PMID 40638086; PMCID PMC12280946.

Read more →
Source

Active vitamin D protects against osteoporosis by promoting VDR-dependent CDK2 transcription and P27 degradation.

Published in Xu F, Liu Q, Huang M, Wang J, Goltzman D, Gu B, Miao D. European journal of endocrinology (2026).

Publication details

[7] Active vitamin D protects against osteoporosis by promoting VDR-dependent CDK2 transcription and P27 degradation. Xu F, Liu Q, Huang M, Wang J, Goltzman D, Gu B, Miao D. European journal of endocrinology. 2026;195(2):329-344. DOI 10.1093/ejendo/lvag152; PMID 42592858.

Read more →
Source

Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial.

Published in Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in immunology (2025).

Publication details

[8] Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in immunology. 2025;16:1570441. DOI 10.3389/fimmu.2025.1570441; PMID 40421021; PMCID PMC12104082.

Read more →
Source

Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial

Published in Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in Immunology (2025).

Publication details

[9] Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in Immunology. 2025;16:1627178. DOI 10.3389/fimmu.2025.1627178; PMID 40510343.

Read more →